The subgroup analysis showed that a high expression of HIGD2A predominantly influenced the prognosis of patients with tumor stages T1, N0, and M0, and pathological stage (Additional file 1: Fig. S1G–J). The gene discussed is HIGD2A; the disease is neoplasm.